Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Recombinant Human Erythropoietin Use in ICU Patients: Does it Prevent Acute Renal Failure?

NCT00676234 is registered in ClinicalTrials.gov with University Hospital, Geneva as lead sponsor.

NCT NCT00676234
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00676234 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Recombinant Human Erythropoietin Use in ICU Patients: Does it Prevent Acute Renal Failure?
Lead sponsor
University Hospital, Geneva
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2008
Completion date
June 30, 2009
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute renal failure